Citigroup Reinstates Buy on Eli Lilly, Announces $1060 Price Target
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Peter Verdult has reinstated a Buy rating on Eli Lilly (NYSE:LLY) and set a price target of $1060.
September 13, 2024 | 1:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup analyst Peter Verdult has reinstated a Buy rating on Eli Lilly and set a price target of $1060, indicating a positive outlook for the stock.
The reinstatement of a Buy rating and a high price target from a major financial institution like Citigroup is likely to boost investor confidence and positively impact Eli Lilly's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100